Thromboembolism in Psychiatric Diseases

National Institution for Clinical Excellence. Venous thromboembolism: Reducing the risk for patients in hospital. January 2010. https://www.nice.org.uk/guidance/cg92.

Streiff MB, Agnelli G, Connors JM et al. The best studied and validated models are the Wells’ criteria for DVT and PE diagnosis and the Geneva Score for PE diagnosis. J. Thromb. Thrombolysis 2016; 41: 32–67. DOI: 10.1007/s11239-015-1317-0

Mazzolai L, Aboyans V, Ageno W et al. Diagnosis and man- agement of acute deep vein thrombosis: A joint consensus document from the European society of cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function. Eur. Heart J. 2017 Feb 17. DOI: 10.1093/eurheartj/ehx003

Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J. Thromb. Thrombolysis 2016; 41(1): 3–14. DOI: 10.1007/s11239-015-1311-6

Patel K, Fasanya A, Yadam S et al. Pathogenesis and Epidemiology of Venous Thromboembolic Disease. Crit. Care Nurs. Q. 2017; 40(3): 191–200. DOI: 10.1097/CNQ.0000000000000158

Allaert FA, Benzenine E, Quantin C. Hospital incidence and annual rates of hospitalization for venous thromboembolic disease in France and the USA. Phlebology 2017; 32(7): 443–447. DOI: 10.1177/0268355516653005

Raskob GE, Angchaisuksiri P, Blanco AN et al. Thrombosis: A major contributor to global disease burden. Arterioscler. Thromb. Vasc. Biol. 2014; 34(11): 2363–2371. DOI: 10.1161/ATVBAHA.114.304488

Lindblad B, Eriksson A, Bergqvist D. Autopsy-verified pulmonary embolism in a surgical de- partment: Analysis of the period from 1951 to 1988. Br. J. Surg. 1991; 78(7): 849–852. DOI: 10.1002/bjs.1800780725

Stein PD, Henry JW. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest. 1995; 108(4): 978–981. DOI: 10.1378/chest.108.4.978

Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: Are we de- tecting enough deep vein thrombosis? J. R. Soc. Med. 1989; 82(4): 203–205. DOI: 10.1177/014107688908200407

Anderson FA Jr, Zayaruzny M, Heit JA et al. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am. J. Hematol. 2007; 82(9): 777–782. DOI: 10.1002/ajh.20983

Konstantinides SV, Torbicki A, Agnelli G et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur. Heart J. 2014; 35(43): 3033–3069, 3069a–3069k. DOI: 10.1093/eurheartj/ehu283

Delluc A, Montavon S, Canceil O et al. Incidence of venous thromboembolism in psychiatric units. Thromb. Res. 2012; 130(6): e283–288. DOI: 10.1016/j.thromres.2012.10.002

Ishida T, Katagiri T, Uchida H et al. Incidence of deep vein thrombosis in restrained psychiatric patients. Psychosomatics 2014; 55(1): 69–75. DOI: 10.1016/j.psym.2013.04.001

Mathew JC, Pillai U, Lacasse A. Extensive Deep Venous Thrombosis in a Patient with Neurolept Malignant Syndrome despite Being on Prophylaxis. Case Rep. Psychiatry 2011; 2011: 258172. DOI: 10.1155/2011/258172

McCall WV, Mann SC, Shelp FE et al. Fatal pulmonary embolism in the catatonic syndrome: Two case reports and a literature review. J. Clin. Psychiatry 1995; 56(1): 21–25. PMID: 7836335

Ishida T, Sakurai H, Watanabe K et al. Incidence of deep vein thrombosis in catatonic patients: A chart review. Psychiatry Res. 2016; 241: 61–65. DOI: 10.1016/j.psychres.2016.04.105

Känel von R. Acute mental stress and hemostasis: When physiology becomes vascular harm. Thromb. Res. 2015; 135(Suppl. 1): S52–S55. DOI: 10.1016/S0049-3848(15)50444-1

Masopust J, Mal R, Vali M. Risk of venous thromboembolism during treatment with antipsychotic agents. Psychiatry Clin. Neurosci. 2012; 66: 541–552. DOI: 10.1111/pcn.12001

Hsu WY, Lane HY, Lin CL et al. A population-based cohort study on deep vein thrombo- sis and pulmonary embolism among schizophrenia patients. Schizophr. Res. 2015; 162(1–3): 248–252. DOI: 10.1016/j.schres.2015.01.012

Chow V, Reddel C, Pennings G et al. Global hypercoagulability in patients with schizophrenia receiving long-term antipsychotic therapy. Schizophr. Res. 2015; 162(1–3): 175–182. Doi: 10.1016/j.schres.2014.12.042. Epub 2015 Jan 27. DOI: 10.1016/j.schres.2014.12.042

Lee CW, Liao CH, L et al. in CL Depression and risk of venous thromboembolism: A population-based retrospective cohort study. Psychosom. Med. 2015; 77(5): 591–598. DOI: 10.1097/psy.0000000000000193

Känel von R, Margani A, Stauber S et al. Depressive symptoms as a novel risk factor for recurrent tenous thromboembolism: A longitudinal observational study in patients referred for thrombophilia investigation. PLoS One 2015; 10(5): e0125858. DOI: 10.1371/journal.pone.0125858

Strudsholm U, Johannessen L, Foldager L et al. Increased risk for pulmonary embolism in patients with bipolar disorder. Bipolar Disord. 2005; 7(1): 77–81. DOI: 10.1111/j.1399-5618.2004.00176.x

Robicsek O, Makhoul B, Klein E et al. Hypercoagulation in chronic posttrau- matic stress disorder. Isr. Med. Assoc. J. 2011; 13: 548–552. PMID: 21991715

Hägg S, Jönsson AK, Spigset O. Risk of venous thromboembolism due to antipsychotic drug therapy. Expert. Opin. Drug Saf. 2009; 8(5): 537–547. DOI: 10.1517/14740330903117271

Bałkowiec-Iskra E, Cessak G, Kryńska Ł et al. Venous thromboembolism as an adverse effect of antipsychotic treatment. Psychiatr. Pol. 2014; 48(5): 997–1014. DOI: 10.12740/pp/23018

Letmaier M, Grohmann R, Kren C et al. Venous thromboembolism during treatment with antipsychotics: Results of a drug surveillance program. World J. Biol. Psychiatry. 2018; 19(3): 175–186. DOI: 10.1080/15622975.2017.1285048

Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembo- lism: Nested case-control study. BMJ 2010; 341: c4245. DOI: https://doi.org/10.1136/bmj.c4245

Halacheva K, Dimova S, Tolev T et al. Elevated anticardiolipin an- tibodies in schizophrenic patients before and during neuroleptic medication. Psychiatry Res. 2009; 169(1): 51–55. DOI: 10.1016/j.psychres.2008.05.011

Chang SH, Chiang SY, Chiu CC et al. Expression of anticardio- lipin antibodies and inflammatory associated factors in patients with schizophrenia. Psychiatry Res. 2011; 187: 341–346. DOI: 10.1016/j.psychres.2010.04.049

Borras L, Eytan A, Timary de P et al. Pulmonary thrombo- embolism associated with olanzapine and risperidone. J. Emerg. Med. 2007; 35(2): 159–161. DOI: 10.1016/j.jemermed.2007.07.074

Malý R, Masopust J, Hosák L et al. Four cases of venous thromboembolism associated with olanzapine. Psychiatry Clin. Neurosci. 2009; 63(1): 116–118. DOI: 10.1111/j.1440-1819.2008.01899.x

Lacut K, Le Gal G, Couturaud F et al. Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: Results from the EDITH case-control study. Fundam. Clin. Pharmacol. 2007; 21(6): 643–650. DOI: 10.1111/j.1472-8206.2007.00515.x

Liperoti R, Pedone C, Lapane KL et al. Venous thromboembolism among elderly patients treated with atypical and first-generation antipsychotic agents. Arch. Intern. Med. 2005; 165(22): 2677–2682.DOI:10.1001/archinte.165.22.2677

Khammassi N, Chrifi J, Hamza M et al. Specific treatments of the psychiatric community and thrombogenesis. Encephale. 2013; 39(2): 143–148. DOI: 10.1016/j.encep.2012.06.007

Wu CS, Chang CM, Chen CY et al. Association between an- tidepressants and venous thromboembolism in Taiwan. J. Clin. Psychopharmacol. 2013; 33(1): 31–37 DOI: 10.1097/JCP.0b013e3182777425